Vicarious Surgical (RBOT) Scheduled to Post Quarterly Earnings on Monday

Vicarious Surgical (NYSE:RBOTGet Free Report) is set to announce its earnings results after the market closes on Monday, April 29th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Vicarious Surgical (NYSE:RBOTGet Free Report) last posted its earnings results on Monday, March 4th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.05. During the same period last year, the firm earned ($0.16) earnings per share. On average, analysts expect Vicarious Surgical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Vicarious Surgical Price Performance

Shares of Vicarious Surgical stock opened at $0.27 on Friday. The firm has a market cap of $47.45 million, a price-to-earnings ratio of -0.55 and a beta of 1.18. The stock’s 50-day moving average is $0.33 and its 200-day moving average is $0.37. Vicarious Surgical has a one year low of $0.20 and a one year high of $2.46.

Analyst Upgrades and Downgrades

Separately, Piper Sandler cut their price target on Vicarious Surgical from $1.50 to $1.00 and set a “neutral” rating on the stock in a report on Tuesday, March 5th.

Read Our Latest Report on Vicarious Surgical

Vicarious Surgical Company Profile

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Featured Articles

Earnings History for Vicarious Surgical (NYSE:RBOT)

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.